1. Home
  2. TTE vs NVO Comparison

TTE vs NVO Comparison

Compare TTE & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TotalEnergies SE

TTE

TotalEnergies SE

N/A

Current Price

$85.44

Market Cap

209.9B

Sector

Energy

ML Signal

N/A

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

N/A

Current Price

$37.97

Market Cap

199.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TTE
NVO
Founded
1924
1923
Country
France
Denmark
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
209.9B
199.4B
IPO Year
1999
2001

Fundamental Metrics

Financial Performance
Metric
TTE
NVO
Price
$85.44
$37.97
Analyst Decision
Buy
Hold
Analyst Count
10
13
Target Price
★ $100.85
$45.73
AVG Volume (30 Days)
1.2M
★ 10.1M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 4.64%
3.30%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.40
$0.47
Revenue Next Year
N/A
$0.96
P/E Ratio
★ $12.60
$13.60
Revenue Growth
N/A
N/A
52 Week Low
$62.16
$35.12
52 Week High
$95.78
$64.16

Technical Indicators

Market Signals
Indicator
TTE
NVO
Relative Strength Index (RSI) 35.89 38.84
Support Level $85.09 $37.61
Resistance Level $91.32 $39.64
Average True Range (ATR) 1.61 1.00
MACD -0.57 -0.23
Stochastic Oscillator 0.62 2.31

Price Performance

Historical Comparison
TTE
NVO

About TTE TotalEnergies SE

TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2025, it produced 1.5 million barrels of liquids and 5.4 billion cubic feet of natural gas per day. At the end of 2025, reserves stood at 11.2 billion barrels of oil equivalent, 55% of which are liquids. During 2025, it had LNG sales of 43.9 million metric tons. The company owns interests in refineries with a capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. At year-end, its gross installed renewable power generation capacity was 34 gigawatts.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: